Interferon-alpha and MxA inhibit BK polyomavirus replication by interaction with polyomavirus large T antigen

Hsin-Hsu Wu1, Yi-Jung Li2, Cheng-Hao Weng2

  • 1Kidney Research Center, Department of Nephrology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Medicine, Chang Gung University, Taoyuan, Taiwan; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taiwan.

Biomedical Journal
|December 8, 2023
PubMed
Abstract

Insights

Interferon alpha (IFNα) and its protein MxA show antiviral effects against BK Polyomavirus (BKPyV). MxA inhibits BKPyV by interacting with TAg, preventing its nuclear translocation, crucial for antiviral activity.

Area of Science:

  • Virology
  • Immunology
  • Nephrology

Background:

  • BK Polyomavirus (BKPyV) infection is a significant complication in kidney transplant recipients, leading to graft failure.
  • Current treatment options for BKPyV infection are limited, with no effective antiviral agents available.
  • Understanding the host immune response against BKPyV is critical for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the antiviral effects of Interferon alpha (IFNα) and its downstream protein MxA against BK Polyomavirus (BKPyV).
  • To elucidate the mechanism by which MxA exerts its antiviral activity against BKPyV.

Main Methods:

  • In vitro cell culture experiments using human primary renal proximal tubular epithelial cells (HRPTECs).
  • In vivo animal studies involving Balb/c mice subjected to unilateral kidney ischemic reperfusion injury.
  • Analysis of BKPyV TAg and VP1 production, MxA interaction with TAg, and functional assessment of MxA mutants.

Main Results:

  • IFNα demonstrated effective inhibition of BKPyV in vitro and murine polyomavirus in vivo.
  • Both IFNα and MxA suppressed the production of BKPyV TAg and VP1.
  • MxA interaction with BKPyV TAg was essential for antiviral activity, preventing TAg nuclear translocation. MxA K83A mutant retained interaction and antiviral effect, while T103A mutant lost both.

Conclusions:

  • Interferon alpha (IFNα) and its induced protein MxA possess potent antiviral properties against BKPyV.
  • The interaction between MxA and BKPyV TAg is a key mechanism underlying MxA's anti-BKPyV effects.
  • These findings highlight the therapeutic potential of IFNα and MxA in managing BKPyV infections, particularly in immunocompromised individuals.